ArticleJournal of clinical and experimental hepatology

Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.

Özlem Akdoğan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.